Dolores Acuña, Stephanie Goya, Mercedes S Nabaes Jodar, Érica Grandis, Mistchenko Alicia S, Mariana Viegas
Virology Laboratory, Ricardo Gutierrez Children's Hospital, Buenos Aires City, Argentina; National Scientific and Technical Research Council, Argentina.
Virology Laboratory, Ricardo Gutierrez Children's Hospital, Buenos Aires City, Argentina.
J Clin Virol. 2022 Apr;149:105126. doi: 10.1016/j.jcv.2022.105126. Epub 2022 Mar 9.
The community mitigation measures taken because of the COVID-19 pandemic had side effects on the circulation of the most frequent respiratory viruses during 2020. In the case of respiratory syncytial virus (RSV), an important paediatric pathogen, a decrease in the number of cases and delayed outbreaks was previously described.
The genetic characteristics of the RSV circulating strains in paediatric patients in Buenos Aires, Argentina before and during the COVID-19 pandemic were studied. RSV (+) samples taken from hospitalised patients with respiratory tract infections (2018- 2021) were analysed through G gene sequencing and evolutionary analyses.
No RSV hospitalised paediatric patients were registered in Buenos Aires during 2020; however, RSV reemerged in 2021 with a lower number of cases and a delayed outbreak, peaking in July-August. A total of 147 G gene sequences were analysed. RSV-B (N = 85) predominated during 2018 and 2021 whereas in 2019 RSV-A were more prevalent (N = 62). All RSV-A sequences were ON1-like strains, and all RSV-B were BA-like. Phylogenetic analyses showed that the same genetic lineages circulated before and after 2020, but RSVs from 2021 corresponded to new viral introductions rather than cryptic circulation of the previous genetic clusters in Buenos Aires during 2020.
Following the reopening of borders, the reemergence of RSV in Argentina brought new viral introductions from other countries. Therefore, it is important to continue a deep global molecular surveillance to characterise RSV strains in post-pandemic circulation with an impact in future vaccine implementation.
由于新冠疫情而采取的社区缓解措施对2020年期间最常见呼吸道病毒的传播产生了副作用。对于呼吸道合胞病毒(RSV)这种重要的儿科病原体,此前曾描述过病例数减少和疫情爆发延迟的情况。
研究了新冠疫情之前及期间阿根廷布宜诺斯艾利斯市儿科患者中RSV流行毒株的基因特征。通过G基因测序和进化分析,对从呼吸道感染住院患者(2018 - 2021年)采集的RSV(+)样本进行了分析。
布宜诺斯艾利斯市在2020年没有登记到RSV住院儿科患者;然而,RSV在2021年再次出现,病例数较少且疫情爆发延迟,在7 - 8月达到高峰。共分析了147条G基因序列。2018年和2021年RSV - B(N = 85)占主导,而2019年RSV - A更为流行(N = 62)。所有RSV - A序列均为ON1样毒株,所有RSV - B均为BA样。系统发育分析表明,2020年前后相同的基因谱系在传播,但2021年的RSV对应于新的病毒引入,而非2020年期间布宜诺斯艾利斯市之前基因簇的隐匿传播。
随着边境重新开放,RSV在阿根廷的再次出现带来了来自其他国家的新病毒引入。因此,持续进行深入的全球分子监测以鉴定大流行后传播的RSV毒株特征对于未来疫苗的应用具有重要意义。